Thus, signaling through the ATM/Chk2/p53 pathway promotes glioma radioresistance by activating DDR and inducing cell cycle arrest, suggesting that enhanced radiosensitivity and prolong patient survival might be achieved using inhibitors of ATM kinase or its substrates. Here, CHEK2 is linked to central nervous system cancer.